id | C00044435 |
---|---|
Name | 3,5,4'-Trihydroxystilbene |
CAS RN | 133294-37-8 |
Standard InChI | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ |
Standard InChI (Main Layer) | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H |
Phytochemical cluster | No. 13 |
---|---|
KCF-S cluster | No. 295 |
By standard InChI | CHEMBL165 |
---|---|
By standard InChI Main Layer | CHEMBL165 CHEMBL87333 CHEMBL2019155 |
By LinkDB | C03582 |
---|
By CAS RN |
---|
class name | count |
---|---|
eudicotyledons | 1 |
family name | count |
---|---|
Polygonaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Rumex bucephalophorus | 242533 | Polygonaceae | eudicotyledons | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL165 CHEMBL87333 |
CHEMBL1614110
(2)
CHEMBL1741321
(2)
CHEMBL1909136 (2) |
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL165 |
CHEMBL1613805
(1)
CHEMBL1614293
(1)
|
0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | CHEMBL165 |
CHEMBL953268
(1)
|
0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL165 CHEMBL87333 |
CHEMBL1613992
(4)
CHEMBL1613995
(3)
CHEMBL1738132 (1) |
7 / 44 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL165 CHEMBL87333 |
CHEMBL1613842
(5)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL165 |
CHEMBL1794367
(1)
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL165 |
CHEMBL1794499
(1)
|
2 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | CHEMBL87333 |
CHEMBL1614177
(1)
CHEMBL1614265
(1)
|
0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL165 |
CHEMBL1909139
(2)
|
0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL87333 |
CHEMBL1059215
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL165 |
CHEMBL869264
(1)
CHEMBL868097
(1)
CHEMBL906707 (1) CHEMBL932255 (1) CHEMBL1020816 (1) CHEMBL941537 (1) CHEMBL1008495 (1) CHEMBL1176361 (1) CHEMBL1176362 (1) CHEMBL1909131 (2) |
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL165 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL165 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL165 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL165 |
CHEMBL1909201
(2)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL165 |
CHEMBL1614079
(1)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL165 |
CHEMBL1909176
(2)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL165 |
CHEMBL1614076
(1)
|
1 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227478
(1)
CHEMBL2019846
(1)
|
0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227477
(1)
CHEMBL2019852
(1)
|
0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227480
(1)
CHEMBL2019848
(1)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL165 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL165 |
CHEMBL1821182
(1)
CHEMBL1821183
(1)
CHEMBL1821184 (1) CHEMBL1821186 (1) CHEMBL1909198 (2) |
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL165 |
CHEMBL1909199
(2)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL165 |
CHEMBL1794524
(1)
CHEMBL1794552
(1)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL165 |
CHEMBL1909197
(2)
|
2 / 2 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227626
(1)
CHEMBL2019849
(1)
|
0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | CHEMBL165 |
CHEMBL1799589
(1)
|
0 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL87333 |
CHEMBL1614331
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL165 CHEMBL87333 |
CHEMBL1614310
(1)
CHEMBL1614544
(3)
|
11 / 10 |
P55789 | FAD-linked sulfhydryl oxidase ALR | Enzyme | CHEMBL165 |
CHEMBL1738573
(1)
|
1 / 0 |
P09960 | Leukotriene A-4 hydrolase | M1 | CHEMBL165 |
CHEMBL1032963
(1)
CHEMBL1032964
(1)
|
0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL165 |
CHEMBL1613776
(1)
|
3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227474
(1)
CHEMBL1909123
(2)
CHEMBL2019838 (1) |
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL165 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL165 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL165 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL165 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL165 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909093
(2)
|
0 / 0 |
P02768 | Serum albumin | Secreted protein | CHEMBL165 |
CHEMBL953986
(1)
CHEMBL953987
(1)
CHEMBL953988 (1) |
0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL165 |
CHEMBL1743521
(1)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL165 |
CHEMBL861699
(1)
CHEMBL861700
(1)
|
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL165 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL165 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL165 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL165 CHEMBL87333 |
CHEMBL1614027
(3)
CHEMBL1741325
(2)
CHEMBL1909135 (2) |
0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL165 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL165 |
CHEMBL1614166
(1)
|
1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL165 |
CHEMBL1909203
(2)
|
1 / 11 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL165 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL165 |
CHEMBL863436
(1)
CHEMBL866165
(1)
CHEMBL868097 (1) CHEMBL932254 (1) CHEMBL1020815 (1) CHEMBL941536 (1) CHEMBL1008496 (1) CHEMBL1909130 (2) |
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL165 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL165 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL165 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL165 |
CHEMBL1909214
(2)
|
0 / 0 |
P11926 | Ornithine decarboxylase | Lyase | CHEMBL165 |
CHEMBL970064
(1)
|
0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227479
(1)
CHEMBL2019847
(1)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL165 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL165 |
CHEMBL1909096
(2)
|
1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL165 |
CHEMBL1613800
(1)
|
0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL165 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL165 |
CHEMBL1909166
(2)
|
1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227627
(1)
CHEMBL2019850
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1614458
(7)
|
0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227625
(1)
CHEMBL2019842
(1)
|
1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL165 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL165 CHEMBL87333 |
CHEMBL1614456
(3)
CHEMBL1613803
(3)
|
0 / 0 |
Q8IXJ6 | NAD-dependent protein deacetylase sirtuin-2 | Enzyme | CHEMBL165 |
CHEMBL933818
(1)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL87333 |
CHEMBL1738606
(1)
|
0 / 0 |
Q12778 | Forkhead box protein O1 | Unclassified protein | CHEMBL165 |
CHEMBL2353207
(1)
|
1 / 2 |
P42858 | Huntingtin | Unclassified protein | CHEMBL165 |
CHEMBL1614147
(1)
|
1 / 1 |
O75496 | Geminin | Unclassified protein | CHEMBL165 |
CHEMBL2114843
(1)
|
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL165 |
CHEMBL1613838
(2)
|
0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL165 |
CHEMBL2114807
(1)
|
4 / 2 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL165 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL165 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL165 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL165 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL165 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL165 |
CHEMBL1647075
(1)
CHEMBL1647190
(1)
CHEMBL1647194 (1) CHEMBL1909146 (2) |
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL165 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL165 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL165 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL165 |
CHEMBL1909167
(2)
|
1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227473
(1)
CHEMBL2019836
(1)
|
0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL165 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL165 |
CHEMBL1909194
(2)
|
0 / 0 |
P07711 | Cathepsin L1 | C1A | CHEMBL165 |
CHEMBL1614088
(1)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL165 |
CHEMBL1909110
(2)
|
1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL165 |
CHEMBL2114788
(1)
|
0 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL165 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL165 |
CHEMBL1909119
(2)
|
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL165 |
CHEMBL1738610
(1)
|
0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL165 |
CHEMBL1794423
(1)
CHEMBL1963893
(1)
|
0 / 0 |
Q9NZ45 | CDGSH iron-sulfur domain-containing protein 1 | Unclassified protein | CHEMBL165 |
CHEMBL1826573
(1)
|
0 / 0 |
P01106 | Myc proto-oncogene protein | Unclassified protein | CHEMBL165 |
CHEMBL2353443
(1)
CHEMBL2353444
(1)
|
1 / 15 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL165 |
CHEMBL1794382
(2)
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL165 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL165 |
CHEMBL1909170
(2)
|
0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | CHEMBL165 CHEMBL87333 |
CHEMBL949646
(1)
CHEMBL960910
(1)
CHEMBL1176011 (1) CHEMBL1941244 (2) CHEMBL1941245 (2) CHEMBL1961307 (1) CHEMBL1961308 (1) CHEMBL2213354 (1) CHEMBL2213355 (1) |
2 / 2 |
P14679 | Tyrosinase | Oxidoreductase | CHEMBL165 |
CHEMBL1013463
(1)
CHEMBL1780390
(1)
|
4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL165 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL165 |
CHEMBL1909109
(2)
|
2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL165 |
CHEMBL1794293
(1)
CHEMBL1794510
(2)
|
5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL165 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL165 |
CHEMBL1909172
(2)
|
1 / 0 |
P16083 | Ribosyldihydronicotinamide dehydrogenase [quinone] | Enzyme | CHEMBL165 |
CHEMBL960909
(1)
CHEMBL1065027
(1)
CHEMBL1109212 (1) CHEMBL1693919 (1) |
0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL165 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL165 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL165 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL165 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL165 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL165 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL165 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL165 CHEMBL87333 |
CHEMBL1741322
(2)
CHEMBL1909132
(2)
|
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1228226
(1)
CHEMBL2019840
(1)
|
0 / 1 |
Q9NTG7 | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Enzyme | CHEMBL165 |
CHEMBL933819
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1613910
(4)
CHEMBL1614227
(5)
|
3 / 3 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL165 |
CHEMBL1006005
(1)
|
1 / 1 |
O43524 | Forkhead box protein O3 | Unclassified protein | CHEMBL165 |
CHEMBL946591
(1)
CHEMBL946592
(1)
CHEMBL948616 (1) CHEMBL948620 (1) CHEMBL948623 (1) |
0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1614038
(7)
|
2 / 2 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL165 |
CHEMBL1614342
(2)
|
1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL165 |
CHEMBL1614171
(1)
|
5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL165 |
CHEMBL2114842
(1)
|
0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL165 |
CHEMBL1738588
(1)
CHEMBL1738675
(1)
CHEMBL1737868 (1) CHEMBL1738317 (1) |
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL165 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL165 |
CHEMBL829990
(1)
CHEMBL1647192
(1)
CHEMBL1647195 (1) CHEMBL1794364 (2) CHEMBL1794542 (2) CHEMBL1909145 (2) |
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL165 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL165 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL165 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL165 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL165 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL165 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL165 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL165 |
CHEMBL1909168
(2)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL87333 |
CHEMBL1614240
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL165 |
CHEMBL948617
(1)
CHEMBL948618
(1)
CHEMBL948621 (1) |
4 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL165 CHEMBL87333 |
CHEMBL1613777
(2)
CHEMBL1741323
(2)
CHEMBL1909134 (2) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL165 CHEMBL87333 |
CHEMBL1614108
(4)
CHEMBL1613886
(4)
CHEMBL1741324 (2) CHEMBL1743448 (1) CHEMBL1743460 (2) CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL165 |
CHEMBL1909137
(2)
|
0 / 0 |
Q96EB6 | NAD-dependent protein deacetylase sirtuin-1 | Enzyme | CHEMBL165 |
CHEMBL933817
(2)
CHEMBL933820
(1)
CHEMBL930181 (1) CHEMBL995952 (1) CHEMBL995953 (1) CHEMBL999423 (1) CHEMBL999424 (1) CHEMBL2345564 (1) CHEMBL2345566 (1) CHEMBL2345569 (1) CHEMBL2343193 (1) CHEMBL2343194 (1) |
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL165 |
CHEMBL1794483
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1614211
(2)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL165 CHEMBL87333 |
CHEMBL1614250
(2)
CHEMBL1614421
(6)
CHEMBL1614502 (6) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL165 |
CHEMBL1738402
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL165 |
CHEMBL1737980
(1)
CHEMBL2114890
(2)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL165 |
CHEMBL1794321
(1)
CHEMBL1794560
(2)
|
3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL165 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL165 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL165 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL165 |
CHEMBL1909116
(2)
|
1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227475
(1)
CHEMBL2019844
(1)
|
0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL165 |
CHEMBL765997
(1)
CHEMBL1909206
(2)
|
0 / 1 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | CHEMBL165 |
CHEMBL1647069
(1)
CHEMBL1647070
(1)
CHEMBL2114849 (2) |
0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL165 |
CHEMBL1909128
(2)
|
0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | CHEMBL165 CHEMBL2019155 |
CHEMBL1227476
(1)
CHEMBL2019845
(1)
|
1 / 1 |
Q07817 | Bcl-2-like protein 1 | Other cytosolic protein | CHEMBL165 |
CHEMBL1107439
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1794536
(2)
|
0 / 0 |
P11169 | Solute carrier family 2, facilitated glucose transporter member 3 | Unclassified protein | CHEMBL165 |
CHEMBL940498
(1)
CHEMBL940499
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1613914
(6)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL87333 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL165 |
CHEMBL1738442
(1)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL87333 |
CHEMBL1614364
(1)
|
1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL165 |
CHEMBL2354311
(1)
|
1 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL165 CHEMBL87333 |
CHEMBL1614257
(6)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL165 CHEMBL87333 |
CHEMBL1614257
(6)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL165 |
CHEMBL1613933
(1)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL165 |
CHEMBL1613933
(1)
|
1 / 6 |
P00519 | Tyrosine-protein kinase ABL1 | Abl | CHEMBL165 |
CHEMBL861701
(1)
CHEMBL861702
(1)
|
1 / 4 |
P11274 | Breakpoint cluster region protein | Bcr | CHEMBL165 |
CHEMBL861701
(1)
CHEMBL861702
(1)
|
1 / 4 |
Q00653 | Nuclear factor NF-kappa-B p100 subunit | Transcription Factor | CHEMBL165 |
CHEMBL1613870
(1)
|
0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | CHEMBL165 |
CHEMBL1613870
(1)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL165 |
CHEMBL1613870
(1)
|
0 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P31749
P38398 |
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#113970 | Burkitt lymphoma; bl |
P01106
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P31749
|
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#608232 | Leukemia, chronic myeloid; cml |
P00519
P11274 |
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
P55789
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
P38398 |
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#176920 | Proteus syndrome |
P31749
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#268220 | Rhabdomyosarcoma 2; rms2 |
Q12778
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
P00519
(related)
P00519 (marker) P01106 (related) P01106 (marker) P11274 (related) P11274 (marker) Q01196 (related) Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
P00519
(related)
P00519 (marker) P04637 (related) P11274 (related) P11274 (marker) Q01196 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P01106 (related) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P01106 (related) P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P01106 (related) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
P01106
(related)
Q03164 (related) |
H00008 | Burkitt lymphoma |
P01106
(related)
P01106 (marker) P04637 (related) |
H00010 | Multiple myeloma |
P01106
(related)
P04637 (related) |
H00013 | Small cell lung cancer |
P01106
(related)
P04637 (related) |
H00025 | Penile cancer |
P01106
(related)
P04637 (related) P04637 (marker) P14780 (related) P35354 (related) |
H00027 | Ovarian cancer |
P01106
(related)
P04626 (related) P04637 (related) P38398 (related) |
H00031 | Breast cancer |
P01106
(related)
P04626 (related) P04626 (marker) P04637 (related) P38398 (related) |
H00036 | Osteosarcoma |
P01106
(related)
P04637 (related) P08684 (marker) |
H00041 | Kaposi's sarcoma |
P01106
(related)
P04637 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00037 | Alveolar rhabdomyosarcoma |
Q12778
(related)
Q12778 (marker) |
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|